Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 50 of 91 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/31/14
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 01/31/11
End: 08/31/12
Due: 08/31/13
Phase: N/A
Priority: Normal
Start: 01/31/06
End: 09/30/06
Due: 09/30/07
Phase: N/A
Priority: Normal
Start: 08/01/20
End: 03/31/24
Due: 03/31/25
Phase: N/A
Priority: Normal
Start: 06/30/11
End: 07/31/11
Due: 07/31/12
Phase: N/A
Priority: Normal
Start: 09/30/11
End: 12/31/12
Due: 12/31/13
Phase: N/A
Priority: Normal
Start: 08/20/23
End: 03/20/24
Due: 03/20/25
Phase: N/A
Priority: Normal
Start: 08/20/20
End: 08/31/22
Due: 08/31/23
Phase: N/A
Priority: Normal
Start: 06/30/13
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 01/31/10
End: 01/31/12
Due: 01/31/13
Phase: N/A
Priority: Normal
Start: 07/31/13
End: 04/30/14
Due: 04/30/15
Phase: N/A
Priority: Normal
Start: 10/31/10
End: 05/31/11
Due: 05/31/12
Phase: N/A
Priority: Normal
Start: 01/31/11
End: 01/31/12
Due: 01/31/13
Phase: N/A
Priority: Normal
Start: 12/04/23
End: 01/21/25
Due: 01/21/26
Phase: N/A
Priority: Normal
Start: 12/31/15
End: 06/30/16
Due: 06/30/17
Phase: N/A
Priority: Normal
Start: 05/31/13
End: 12/31/16
Due: 12/31/17
Phase: N/A
Priority: Normal
Start: 07/22/16
End: 12/30/18
Due: 12/30/19
Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma
Phase: N/A
Priority: Normal
Start: 03/03/18
End: 04/03/21
Due: 04/03/22
Phase: N/A
Priority: Normal
Start: 10/31/09
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 01/31/10
End: 06/30/12
Due: 06/30/13
Phase: N/A
Priority: Normal
Start: 08/31/16
End: 12/31/16
Due: 12/31/17
Phase: N/A
Priority: Normal
Start: 08/31/10
End: 04/30/11
Due: 04/30/12
Phase: N/A
Priority: Normal
Start: 06/30/14
End: 02/28/15
Due: 02/28/16
Phase: N/A
Priority: Normal
Start: 08/20/20
End: 08/20/22
Due: 08/20/23
Phase: N/A
Priority: Normal
Start: 05/31/09
End: 06/30/10
Due: 06/30/11